NCT03592082View on ClinicalTrials.gov

Use of Bismuth Subsalicylate in Clostridium Difficile Colitis

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 1, 2018

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Clostridium Difficile Infection
Interventions
DRUG

Bismuth Subsalicylate

BSS 524 mg ((2) 262 mg tablets) given four times per day for 14 days

DRUG

standard antibiotic therapy

antibiotic therapy administered per standard protocol

Trial Locations (1)

13326

Bassett Healthcare Network, Cooperstown

Sponsors

Lead Sponsor

Bassett Healthcare
All Listed Sponsors
lead

Bassett Healthcare

OTHER